METHODIST DALLAS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7.3M
- Transactions
- 1,659
- Companies
- 40
- Average per transaction
- $4,418
Who reported the payments
| Gilead | $1,579,057 |
| Intercept Pharmaceuticals, Inc. | $857,814 |
| Paratek Pharmaceuticals, Inc. | $694,396 |
| AbbVie | $593,872 |
| Sirtex Medical Inc | $399,905 |
| E.r. Squibb & Sons, L.L.C. | $389,118 |
| Madrigal Pharmaceuticals | $363,556 |
| Intuitive Surgical | $278,931 |
| Astrazeneca UK Limited | $240,812 |
| Angiodynamics, Inc. | $232,780 |
| Hoffmann-la Roche Limited | $173,118 |
| Eli Lilly | $149,345 |
| Taiho Oncology, Inc. | $144,815 |
| Pfizer | $141,917 |
| Intercept Pharma Europe Ltd. | $118,489 |
| Ipsen Bioscience Inc. | $107,325 |
| Takeda Pharmaceuticals U.S.A., Inc. | $97,516 |
| Regeneron | $85,077 |
| Novocure GmbH | $67,600 |
| AstraZeneca | $66,094 |
| Janssen Research & Development, LLC | $65,866 |
| Stryker | $39,961 |
| Cvrx, Inc. | $37,795 |
| Shire North American Group Inc | $35,085 |
| Novocure Inc. | $29,850 |
| Pentax Of America, Inc. | $28,701 |
| Mallinckrodt Hospital Products Inc. | $28,100 |
| Abbott | $27,541 |
| Amgen | $26,083 |
| Vantive US Healthcare LLC | $25,324 |
| Merck | $22,589 |
| EMD Serono, Inc. | $19,600 |
| Zimmer Biomet | $11,576 |
| Novartis | $11,471 |
| Boston Scientific | $10,434 |
| Covidien LP | $10,000 |
| Shionogi Inc | $8,775 |
| Pacira Pharmaceuticals Incorporated | $7,500 |
| Sanofi-aventis U.S. LLC | $7,000 |
| Medline Industries LP | $6,000 |